# An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial

> **NCT06813898** · EARLY_PHASE1 · RECRUITING · sponsor: **Northwestern University** · enrollment: 27 (estimated)

## Conditions studied

- Biochemically Recurrent Prostate Carcinoma
- Prostate Adenocarcinoma

## Interventions

- **PROCEDURE:** Computed Tomography
- **OTHER:** Electronic Health Record Review
- **OTHER:** Flotufolastat F-18 Gallium
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT06813898
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-17
- **Primary completion:** 2027-02-01
- **Final completion:** 2032-02-01
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2025-02-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06813898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06813898, "An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06813898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*